CD14 [gngm]    
Low [qlco]    
Monocytes [cell]    
indicator [irda]    
AGGRESSIVENESS [mobd]    
B-Cell Non-Hodgkin Lymphoma [neop]    
Study [mnob]    
Correlation [qlco]    
Percentage [qnco]    
CD14 [gngm]    
Monocytes [cell]    
PLASMA [bdsu]    
arginase 1 [gngm]    
AGGRESSIVENESS [mobd]    
Patients [podg]    
B-Cell Non-Hodgkin Lymphoma [neop]    
Patients [podg]    
B-Cell Non-Hodgkin Lymphoma [neop]    
Healthy Volunteers [popg]    
Study [mnob]    
peripheral blood monocytes [cell]    
CD14 [gngm]    
Detected [fndg]    
FLOW CYTOMETRY [lbpr]    
Correlation [qlco]    
DISEASE RELAPSE [dsyn]    
Refractory [ftcn]    
PERCENT [qnco]    
CD14 [gngm]    
Monocytes [cell]    
Significantly high [qnco]    
LYMPHOMA [neop]    
Patients [podg]    
Healthy Control [qlco]    
control [qlco]    
LYMPHOMA [neop]    
Higher [qlco]    
Stage III [inpr]    
IV [geoa]    
Stage II [inpr]    
Stage II [inpr]    
Stage III [inpr]    
IV [geoa]    
Lymphoma, Diffuse Large-Cell [neop]    
Pathology [bmod]    
Types [qlco]    
relapsed [tmco]    
Refractory [ftcn]    
Patients [podg]    
Patients [podg]    
Remission [fndg]    
relapsed [tmco]    
Refractory [ftcn]    
Remission [fndg]    
Correlated [qlco]    
Increased [qnco]    
PERCENT [qnco]    
CD14 [gngm]    
Monocytes [cell]    
CD14 [gngm]    
Monocytes [cell]    
Loss [qnco]    
Seen [qlco]    
Patients [podg]    
Higher [qlco]    
Stage [tmco]    
aggressive [mobd]    
Pathology [bmod]    
Relapse [phpr]    
Refractory [ftcn]    
treatment [ftcn]    
Therapeutic [topp]    
strategies [menp]    
Overcome [acty]    
Suppressive [ftcn]    
properties [qlco]    
Monocytes [cell]    
Value [qnco]    
